| 000 | 01499 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516073407.0 | ||
| 264 | 0 | _c20121001 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1432-0851 | ||
| 024 | 7 |
_a10.1007/s00262-011-1168-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStroopinsky, Dina | |
| 245 | 0 | 0 |
_aRituximab-induced direct inhibition of T-cell activation. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cAug 2012 |
||
| 300 |
_a1233-41 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aCell Separation |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aLymphocyte Culture Test, Mixed |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aKatz, Tamar | |
| 700 | 1 | _aRowe, Jacob M | |
| 700 | 1 | _aMelamed, Doron | |
| 700 | 1 | _aAvivi, Irit | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 61 _gno. 8 _gp. 1233-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-011-1168-2 _zAvailable from publisher's website |
| 999 |
_c21465416 _d21465416 |
||